4/17
03:01 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
4/17
03:01 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $65.00 price target on the stock.
4/17
08:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
4/17
08:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
4/16
01:18 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
4/3
07:45 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
4/3
07:27 am
legn
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $82.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $82.00 price target on the stock.
4/3
06:12 am
legn
Legend Biotech initiated with bullish view at Cantor Fitzgerald
Low
Report
Legend Biotech initiated with bullish view at Cantor Fitzgerald
4/1
08:09 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
3/18
02:53 pm
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
3/18
10:17 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/13
08:16 am
legn
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $86.00 price target on the stock.
Medium
Report
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $86.00 price target on the stock.
3/13
08:16 am
legn
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $86.00 price target on the stock.
Medium
Report
Legend Biotech Co. (NASDAQ: LEGN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $86.00 price target on the stock.
3/13
04:43 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/13
04:43 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/12
04:15 pm
legn
Legend Biotech initiated with bullish view at Raymond James
Medium
Report
Legend Biotech initiated with bullish view at Raymond James
3/12
04:15 pm
legn
Legend Biotech initiated with bullish view at Raymond James
Medium
Report
Legend Biotech initiated with bullish view at Raymond James
3/12
11:21 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/12
11:21 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/8
11:22 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/8
11:22 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
3/7
10:24 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
3/7
10:24 am
legn
Legend Biotech Co. (NASDAQ: LEGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
Low
Report
Legend Biotech Co. (NASDAQ: LEGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
3/7
09:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
3/7
09:18 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN